SCHEMBL5214219

SCHEMBL5214219

COc1cccc(Cc2c(CO)nn(C(C)C)c2Sc2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 5/20 0.39
FPR2 P25090 3/20 0.39
IDH1 O75874 1/20 0.37
ADCY10 Q96PN6 1/20 0.37
PPARG P37231 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
CCNB2 O95067 1/20 0.36
CCNE2 O96020 1/20 0.36
CDK1 P06493 1/20 0.36
CDK4 P11802 1/20 0.36
CCNB1 P14635 1/20 0.36
CCND1 P24385 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
LMNA P02545 3/20 0.35
TAAR1 Q96RJ0 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5240819 0.88 MEN1 (0.41) FPR1FPR2IDH1ADCY10PPARG
SCHEMBL5240809 0.87 ADCY10 (0.39) FPR1FPR2IDH1ADCY10PPARG
SCHEMBL5211738 0.81 POLB (0.33) POLB
SCHEMBL5209455 0.79 CYP1A2 (0.31) POLB
SCHEMBL5208321 0.78 PDE4D (0.36) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL14564994 0.77 FLT1 (0.33) CCNB2CCNE2CDK1CDK4CCNB1
SCHEMBL5207787 0.77 FLT1 (0.33)
SCHEMBL5209007 0.76 MRGPRX4 (0.35) MEN1KMT2AADRA1D
SCHEMBL5210534 0.75 GRM5 (0.35)
SCHEMBL5210120 0.74 CNR1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP claimed
EP-1401826-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-31 EP claimed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US claimed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO claimed